Oaktree Acquisition Corp. III Life Sciences (OACC)

OACC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Cash & Equivalents	1.36
Cash & Short-Term Investments	1.36
Prepaid Expenses	0.2
Total Current Assets	1.56
Other Long-Term Assets	193.69
Total Assets	195.25
Accrued Expenses	0.54
Short-Term Debt	0.01
Other Current Liabilities	0.18
Total Current Liabilities	0.73
Other Long-Term Liabilities	200.6
Total Liabilities	201.33
Common Stock	0
Retained Earnings	-6.08
Shareholders' Equity	-6.07
Total Liabilities & Equity	195.25
Total Debt	0.01
Net Cash (Debt)	1.35
Net Cash Per Share	0.12
Filing Date Shares Outstanding	24.58
Total Common Shares Outstanding	24.58
Working Capital	0.83
Book Value Per Share	-0.25
Tangible Book Value	-6.07
Tangible Book Value Per Share	-0.25

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q